Weight Loss News and Research

Latest Weight Loss News and Research

U.S. District Court grants temporary restraining order in Amylin's litigation against Lilly

Amylin Pharmaceuticals, Inc. today announced that the United States District Court for the Southern District of California issued a temporary restraining order (TRO) against Eli Lilly and Company relating to its litigation with respect to the Amylin / Lilly diabetes collaboration agreement.

26 May 2011

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

New findings to be presented from pooled analyses of the STELARA psoriasis clinical development program showed that the safety profile of STELARA and rates of adverse events remained consistent and stable over time in adults with moderate to severe plaque psoriasis receiving up to four years of treatment.

25 May 2011

Studies consistently confirm health benefits of fruit consumption

What do apples, blueberries and prunes have in common? If you guessed that they are all fruits you would be correct. However, that would only be scratching the surface. The fact is that studies consistently confirm the benefits of eating a variety of fruit daily. These benefits include better blood profiles, increased bone density and a strong defense against obesity.

24 May 2011

BMI increase between pregnancies linked to increased risk of gestational diabetes mellitus

Compared with women whose weight remained stable, body mass index gains between the first and second pregnancy were associated with an increased risk of gestational diabetes mellitus in the second pregnancy.

24 May 2011

Low doses of natural Hi-maize resistant starch could improve insulin sensitivity in men at risk for prediabetes

Low doses of natural Hi-maize resistant starch could improve insulin sensitivity in men at risk for prediabetes, according to a study underwritten by National Starch LLC, a business unit of Corn Products International. The American Diabetes Association defines prediabetes as a non-disease state where blood sugar (glucose) levels are higher than normal, but not yet high enough to be diagnosed as diabetes.

23 May 2011

Study shows why individuals with anorexia nervosa have paradoxical response to food

Perhaps the most puzzling symptom of anorexia nervosa - a disorder that tends to occur in young women - is the refusal to eat, resulting in extreme weight loss. While most people have a great deal of difficulty in dieting and losing weight, particularly if a diet extends over many months or years, individuals with anorexia nervosa can literally diet themselves to death. In fact, this disorder has a very high death rate from starvation.

21 May 2011

Diet quality, not quantity, can make a difference in risk for type 2 diabetes

Small differences in diet - even without weight loss - can significantly affect risk for diabetes, according to research from the University of Alabama at Birmingham published online May 18, 2011, by the American Journal of Clinical Nutrition.

20 May 2011

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced results from a Phase 2b trial evaluating Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic breast cancer previously treated with a bevacizumab-containing regimen, which showed that Nexavar was associated with statistically significant improvements in progression-free survival and time-to-progression.

20 May 2011

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Naltrexone reduced inflammation in Crohn's patients in a research study at Penn State College of Medicine.

20 May 2011

$Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma$

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced updated results from the Phase 2b 003-A1 study of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma. Carfilzomib achieved a clinical benefit rate (CBR) (minimal response or greater) in the study population of 37 percent with a duration of response (DOR) of 8.3 months.

20 May 2011

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Use of a simple, at-home screening test by Canadians can prevent many unnecessary colorectal cancer deaths, according to a special report about colorectal cancer in Canadian Cancer Statistics 2011 released today by the Canadian Cancer Society, in collaboration with the Public Health Agency of Canada and Statistics Canada.

19 May 2011

Low calorie sweeteners offer effective solution to manage weight

The desire to eat sweet things does not need to be suppressed, just managed, according to health and nutrition experts meeting at the International Sweeteners Association's conference in Brussels today.

19 May 2011

USPTO grants four key patents for Alvine's proteases to detect celiac disease

Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the United States Patent and Trademark Office has issued four key patents: 7,943,312; 7,928,056; 7,923,532; and 7,910,541, protecting various aspects of Alvine's core technology.

19 May 2011

TurboCharged weight-loss book now available for readers in France

TurboCharged, a new book by brother and sister co-authors Dian Griesel, Ph.D. and Tom Griesel, outlines a revolutionary 8-step rapid fat-loss program requiring no aerobic exercise, supplements or special equipment.

18 May 2011

Eli Lilly responds to Amylin's exenatide lawsuit

Eli Lilly and Company has provided additional perspective in response to Amylin Pharmaceuticals, Inc.'s lawsuit filed in the United States District Court for the Southern District of California.

17 May 2011

Obese, asthmatic children more likely to experience excessive daytime sleepiness

Obese, asthmatic, anxious or depressed children are more likely to experience excessive daytime sleepiness, or EDS, according to Penn State College of Medicine sleep researchers.

17 May 2011

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

Amylin Pharmaceuticals, Inc. today announced that it has filed a lawsuit against Eli Lilly and Company in the United States District Court for the Southern District of California, alleging that Lilly is engaging in anticompetitive activity and breaching its strategic alliance agreements with Amylin to maximize commercialization of exenatide.

16 May 2011

Diet-Bailout author use business tools for new weight loss approach

Rosemary Hershey, author of Diet-Bailout, introduces a new approach to weight loss using business tools that change the way women diet.

13 May 2011

Liver cells made in the lab using skin cells: Study

In a medical breakthrough, researchers have been able to convert skin cells into liver cells. This could one day eliminate the need for organ transplants, they say.

12 May 2011

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced that GATTEX, a novel, recombinant analog of human glucagon-like peptide 2, was found to effectively and safely reduce parenteral support volume in adult short bowel syndrome-intestinal failure patients.

11 May 2011

Weight Loss News and Research

Latest Weight Loss News and Research

U.S. District Court grants temporary restraining order in Amylin's litigation against Lilly

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

Studies consistently confirm health benefits of fruit consumption

BMI increase between pregnancies linked to increased risk of gestational diabetes mellitus

Low doses of natural Hi-maize resistant starch could improve insulin sensitivity in men at risk for prediabetes

Study shows why individuals with anorexia nervosa have paradoxical response to food

Diet quality, not quantity, can make a difference in risk for type 2 diabetes

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Low calorie sweeteners offer effective solution to manage weight

USPTO grants four key patents for Alvine's proteases to detect celiac disease

TurboCharged weight-loss book now available for readers in France

Eli Lilly responds to Amylin's exenatide lawsuit

Obese, asthmatic children more likely to experience excessive daytime sleepiness

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

Diet-Bailout author use business tools for new weight loss approach

Liver cells made in the lab using skin cells: Study

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Weight Loss News and Research

Latest Weight Loss News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in